Obermatt
See Similar Stocks →

Tectonic Therapeutic

NMQ:TECX · US8789721086
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings48
Price/Book49
Dividend Yield—
Revenue Growth—
Profit Growth67
Capital Growth75
TSR 52w27
Leverage69
Liquidity12
Refinancing45
Combined—
Analyst Opinions79
Pro Holdings63
Opinion Changes62
Market Pulse33

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Employees66
Websitetectonictx.com
ISINUS8789721086
Last UpdateApr 2, 2026
Index & Theme
GeneticsPulmonologyCardiovascularImmunologyNephrologyNeurologyCentral Nervous SystemChronic DiseasesNeuroscienceGenetic DisorderBiotechnology

Description

Tectonic Therapeutic, Inc. is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (‘GPCRs’). The company has developed a proprietary techno…

Similar Stocks

The companies this stock is ranked against.

Compare Tectonic Therapeutic with its peers
Tenax Therapeutics
NAQ:TENX
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Cytokinetics
NSQ:CYTK
13
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Quince Therapeutics
NSQ:QNCX
4
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Eupraxia Pharmaceuticals
TOR:EPRX
—
CountryCanada
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Acumen Pharmaceuticals
NSQ:ABOS
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Gain Therapeutics
NMQ:GANX
59
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →